{"id":11459,"date":"2017-08-21T09:44:13","date_gmt":"2017-08-21T07:44:13","guid":{"rendered":"https:\/\/www.bm-t.de\/v4\/2021\/the-next-generation-of-blood-pressure-measurement-bmt-invests-in-redwave-medical-gmbh-via-the-thuringian-start-up-fund-tsf\/"},"modified":"2017-08-21T09:44:13","modified_gmt":"2017-08-21T07:44:13","slug":"the-next-generation-of-blood-pressure-measurement-bmt-invests-in-redwave-medical-gmbh-via-the-thuringian-start-up-fund-tsf","status":"publish","type":"post","link":"https:\/\/www.bm-t.de\/en\/2017-en\/the-next-generation-of-blood-pressure-measurement-bmt-invests-in-redwave-medical-gmbh-via-the-thuringian-start-up-fund-tsf\/","title":{"rendered":"The next generation of blood pressure measurement: bm|t invests in Redwave Medical GmbH via the Thuringian Start-up Fund (TSF)."},"content":{"rendered":"<p>Erfurt\/Jena: Red\u00adwave Med\u00adical GmbH, based in Jena, Ger\u00admany, devel\u00adops and dis\u00adtrib\u00adutes a new type of algo\u00adrithm for blood pres\u00adsure mea\u00adsur\u00ading devices for fast, inex\u00adpen\u00adsive and sim\u00adple deter\u00admi\u00adna\u00adtion of the cen\u00adtral blood pres\u00adsure and for check\u00ading the over\u00adall arte\u00adr\u00adial sta\u00adtus. Due to its patented mea\u00adsure\u00adment tech\u00adnol\u00adogy, the Red\u00adwave algo\u00adrithm is suit\u00adable for the first time for use in home blood pres\u00adsure mon\u00adi\u00adtors and is expected to rev\u00ado\u00adlu\u00adtionise indi\u00advid\u00adual health monitoring.<br>\nRecently, the four-mem\u00adber found\u00ading team was able to close the seed financ\u00ading round and in this con\u00adtext was able to win the Th\u00fcringer Auf\u00adbaubank sub\u00adsidiary bm|t (bm\u2011t beteili\u00adgungs\u00adman\u00adage\u00adment th\u00fcrin\u00adgen gmbh) as lead investor and the expe\u00adri\u00adenced ser\u00adial entre\u00adpre\u00adneur Dr. Ger\u00adhard Scheuch as co-investor.<\/p>\n<h4>Why central blood pressure?<\/h4>\n<p>For years, hyper\u00adten\u00adsion patients have been mea\u00adsur\u00ading their own blood pres\u00adsure at home as part of their ther\u00adapy. This is done with devices on the upper arm or wrist, which gives the blood pres\u00adsure val\u00adues in the arm. How\u00adever, cur\u00adrent stud\u00adies show that cen\u00adtral blood pres\u00adsure (in the aorta) is much more suit\u00adable for guid\u00ading prog\u00adno\u00adsis and ther\u00adapy. This cen\u00adtral blood pres\u00adsure directly affects impor\u00adtant organs such as the heart, kid\u00adneys or brain and is thus respon\u00adsi\u00adble for the risk of heart attack or stroke. Experts already rec\u00adom\u00admend that high blood pres\u00adsure ther\u00adapy be geared to cen\u00adtral blood pres\u00adsure. How\u00adever, there is cur\u00adrently no way for patients to reli\u00adably mea\u00adsure these val\u00adues them\u00adselves at home. Red\u00adwave finally makes it pos\u00adsi\u00adble to deter\u00admine cen\u00adtral blood pres\u00adsure and other health-rel\u00ade\u00advant val\u00adues from the famil\u00adiar cuff mea\u00adsure\u00adment on the&nbsp;arm.<\/p>\n<h4>How was Redwave able to convince the investors?<\/h4>\n<p>The founders are con\u00advinc\u00ading with their exten\u00adsive pro\u00adfes\u00adsional expe\u00adri\u00adence in the field of med\u00adical tech\u00adnol\u00adogy, espe\u00adcially pulse wave analy\u00adsis. The tech\u00adni\u00adcal, med\u00adical and com\u00admer\u00adcial com\u00adpe\u00adtences com\u00adple\u00adment each other per\u00adfectly in the team and are based on many years of coop\u00ader\u00ada\u00adtion. In addi\u00adtion, a pro\u00adto\u00adtype of the algo\u00adrithm is already avail\u00adable and the inno\u00adv\u00ada\u00adtive con\u00adtent as well as the poten\u00adtial for suc\u00adcess have already been con\u00adfirmed in ini\u00adtial dis\u00adcus\u00adsions with customers.<\/p>\n<h4>About Redwave Medical GmbH:<\/h4>\n<p>Red\u00adwave Med\u00adical GmbH was founded on 05 May 2017 and spe\u00adcialises in biosig\u00adnal analy\u00adsis and med\u00adical algo\u00adrithms. Cur\u00adrently, the com\u00adpany is devel\u00adop\u00ading the first algo\u00adrithm for blood pres\u00adsure cuffs that enables the deter\u00admi\u00adna\u00adtion of cen\u00adtral blood pres\u00adsure (in the aorta) and the ver\u00adi\u00adfi\u00adca\u00adtion of the entire arte\u00adr\u00adial sta\u00adtus at&nbsp;home.<\/p>\n<h4>About bm|t<\/h4>\n<p>bm\u2011t beteili\u00adgungs\u00adman\u00adage\u00adment th\u00fcrin\u00adgen gmbh, based in Erfurt, is a sub\u00adsidiary of the Th\u00fcringer Auf\u00adbaubank and one of the first addresses for invest\u00adments in Thuringia. bm|t cur\u00adrently man\u00adages eight funds with a total vol\u00adume of around EUR 320 mil\u00adlion, which invest in inno\u00adv\u00ada\u00adtive com\u00adpa\u00adnies in almost all sec\u00adtors and in all phases of com\u00adpany devel\u00adop\u00adment \u2014 both in the start-up and growth phases or in com\u00adpany suc\u00adces\u00adsion sit\u00adu\u00ada\u00adtions. Cur\u00adrently, around EUR 100 mil\u00adlion is avail\u00adable for early-stage projects, for growth com\u00adpa\u00adnies and for estab\u00adlished medium-sized and large com\u00adpa\u00adnies in Thuringia\u2019s SME sector.<\/p>\n<h4>Contact:<\/h4>\n<p>Red\u00adwave Med\u00adical&nbsp;GmbH<br>\n<em>Ver\u00adena Dittrich<\/em><br>\nMan\u00adag\u00ading Director<br>\nMax-Steen\u00adbeck-Str. 1<br>\n07745&nbsp;Jena<br>\nPhone: +49 174 91 323&nbsp;63<br>\nE\u2011mail: verena.dittrich@redwave-medical.com<\/p>\n<p>bm\u2011t beteili\u00adgungs\u00adman\u00adage\u00adment th\u00fcrin\u00adgen&nbsp;gmbh<br>\n<em>Ste\u00adfan&nbsp;Jahn<\/em><br>\nInvest\u00adment Manager<br>\nGork\u00adistra\u00dfe 9<br>\n99084 Erfurt<br>\nPhone: +49 361 7447\u2013593<br>\nE\u2011mail: stefan.jahn@bm\u2011t.de<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Erfurt\/Jena: Red\u00adwave Med\u00adical GmbH, based in Jena, Ger\u00admany, devel\u00adops and dis\u00adtrib\u00adutes a new type of algo\u00adrithm for blood pres\u00adsure mea\u00adsur\u00ading devices for fast, inex\u00adpen\u00adsive and sim\u00adple deter\u00admi\u00adna\u00adtion of the cen\u00adtral blood pres\u00adsure and for check\u00ading the over\u00adall arte\u00adr\u00adial sta\u00adtus. Due to its patented mea\u00adsure\u00adment tech\u00adnol\u00adogy, the Red\u00adwave algo\u00adrithm is suit\u00adable for the first time&nbsp;for&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[146],"tags":[],"class_list":["post-11459","post","type-post","status-publish","format-standard","hentry","category-2017-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts\/11459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/comments?post=11459"}],"version-history":[{"count":0,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts\/11459\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/media?parent=11459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/categories?post=11459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/tags?post=11459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}